In a retrospective study published in Cancer Imaging, researchers identified magnetic resonance imaging (MRI) features that can differentiate confluent fibrosis (CF) from mass-forming intrahepatic cholangiocarcinoma with an infiltrative tumor margin (mICCITM), demonstrating that combining arterial phase non-enhancement or non-rim enhancement with delayed phase signal homogeneity achieved a diagnostic accuracy of